Cargando…

Breast cancers with EGFR and HER2 co-amplification favor distant metastasis and poor clinical outcome

ErbB signaling serves essential roles in invasive ductal carcinoma (IDC). The aim of the present study was to assess gene amplification in ErbB family members in IDC with clinical implications. Quantitative polymerase chain reaction and fluorescence in situ hybridization were performed on formalin-f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Peng, Pu, Tianjie, Chen, Shinan, Qiu, Yan, Zhong, Xiaorong, Zheng, Hong, Chen, Lina, Bu, Hong, Ye, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696709/ https://www.ncbi.nlm.nih.gov/pubmed/29181099 http://dx.doi.org/10.3892/ol.2017.7051

Ejemplares similares

FGFR1 and HER1 or HER2 co-amplification in breast cancer indicate poor prognosis
por: Chen, Shinan, et al.
Publicado: (2018)

Clinical significance and prognostic value of receptor conversion in hormone receptor positive breast cancers after neoadjuvant chemotherapy
por: Yang, Libo, et al.
Publicado: (2018)

Downregulation of miR-221-3p and upregulation of its target gene PARP1 are prognostic biomarkers for triple negative breast cancer patients and associated with poor prognosis
por: Deng, Ling, et al.
Publicado: (2017)

Response to HER2 Inhibition in a Patient With Brain Metastasis With EGFR TKI Acquired Resistance and an HER2 Amplification
por: Meedendorp, Arenda D., et al.
Publicado: (2018)

CD49f Can Act as a Biomarker for Local or Distant Recurrence in Breast Cancer
por: Ye, Feng, et al.
Publicado: (2017)

Telomere in colorectal cancer associated with distant metastases and predicted a poor prognosis
por: Ye, Xiaorong, et al.
Publicado: (2021)

Clinical significance of HER2 and EGFR expression in colorectal cancer patients with ovarian metastasis
por: Li, Ji-Lin, et al.
Publicado: (2019)

Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer
por: Stahl, Phillip, et al.
Publicado: (2015)

EGFR, HER2, and HER3 protein expression in paired primary tumor and lymph node metastasis of colorectal cancer
por: Ye, Peng, et al.
Publicado: (2022)

Prognosis of radiotherapy in medullary thyroid carcinoma patients without distant metastasis
por: Huang, Shaojun, et al.
Publicado: (2021)

Receptor tyrosine kinase amplification is predictive of distant metastasis in patients with oral squamous cell carcinoma
por: Oikawa, Yu, et al.
Publicado: (2017)

Alterations of the Human Lung and Gut Microbiomes in Non-Small Cell Lung Carcinomas and Distant Metastasis
por: Lu, Hui, et al.
Publicado: (2021)

Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
por: Gen, Soei, et al.
Publicado: (2022)

Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma
por: KATO, HIROAKI, et al.
Publicado: (2013)

HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contexts
por: Eriksson, Pontus, et al.
Publicado: (2017)

Glioblastoma Multiforme With CDKN2A, Loss of PTEN and EGFR Amplification, and Diffuse Distant Organ Metastasis Treated With Six Lines of Therapy: A Case Report and Literature Review
por: Aslan, Ferit, et al.
Publicado: (2022)

HER2-low breast cancer: evolution of HER2 expression from primary tumor to distant metastases
por: Cai, Mengyuan, et al.
Publicado: (2023)

Differential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with MET amplification
por: Tanizaki, J, et al.
Publicado: (2011)

Risk factors for distant metastasis of chondrosarcoma: A population-based study
por: Deng, Guang-Hua, et al.
Publicado: (2023)

MET amplification assessed using optimized FISH reporting criteria predicts early distant metastasis in patients with non-small cell lung cancer
por: Fang, Lianghua, et al.
Publicado: (2018)

EGFR amplification is a putative resistance mechanism for NSCLC–LM patients with TKI therapy and is associated with poor outcome
por: Yang, Hainan, et al.
Publicado: (2022)

Distant metastasis in patients with myxofibrosarcoma
por: Tsuchie, Hiroyuki, et al.
Publicado: (2017)

Expression and significance of Her2 and Ki-67 in gastric adenocarcinoma without distant metastasis: a cohort study
por: Wei, Zhijian, et al.
Publicado: (2020)

HER2 Amplification in Advanced NSCLC Patients After Progression on EGFR-TKI and Clinical Response to EGFR-TKI Plus Pyrotinib Combination Therapy
por: Gan, Jiadi, et al.
Publicado: (2021)

Pre-treatment Serum Lactate Dehydrogenase Predicts Distant Metastasis and Poor Survival in Nasopharyngeal Carcinoma
por: Long, Guoxian, et al.
Publicado: (2019)

Favorable Immune Microenvironment in Patients with EGFR and MAPK Co-Mutations
por: Yang, Wang, et al.
Publicado: (2020)

Impact of EGFR amplification on survival of patients with EGFR exon 20 insertion-positive non-small cell lung cancer
por: Gao, Xin, et al.
Publicado: (2020)

Case Report: Trastuzumab Treatment in Adenosquamous Carcinoma of the Extrahepatic Biliary Tract With Her-2 Amplification
por: Hong, Ye, et al.
Publicado: (2021)

Metastatic Breast Cancer Coexisting With HER-2 Amplification and EGFR Exon 19 Deletion Benefits From EGFR-TKI Therapy: A Case Report
por: Jing, Wei, et al.
Publicado: (2020)

Impact of menopausal status and HER-2/neu protein on efficacy of EGFR-TKI in EGFR mutant patients with non-small cell lung cancer
por: Yin, Zi-Jun, et al.
Publicado: (2018)

HMGA2 Contributes to Distant Metastasis and Poor Prognosis by Promoting Angiogenesis in Oral Squamous Cell Carcinoma
por: Sakata, Junki, et al.
Publicado: (2019)

Detection of cancer before distant metastasis
por: Coumans, Frank AW, et al.
Publicado: (2013)

Prognostic effect of liver metastasis in lung cancer patients with distant metastasis
por: Ren, Yijiu, et al.
Publicado: (2016)

Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
por: Reis-Filho, Jorge S, et al.
Publicado: (2005)

ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines
por: Ayoub, C, et al.
Publicado: (2010)

Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab
por: Fountzilas, George, et al.
Publicado: (2012)

Bone metastatic carcinoma with EGFR amplification and mutation: A case report and literature review
por: Du, Hong-Juan, et al.
Publicado: (2023)

A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2− early breast cancer
por: Gong, Gyungyub, et al.
Publicado: (2017)

The Expression of Aldehyde Dehydrogenase Family in Breast Cancer
por: Qiu, Yan, et al.
Publicado: (2014)

Tongue metastasis as an initial manifestation of Distant metastasis in Oesophageal Adenocarcinoma
por: Tunio, Mutahir A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tppcdvv7j05ij0monck1g6e20d